OBJECTIVES
We aim to establish continuous and long term growth by +15 - 25 % annually by:
- acquiring a minimum of 1 proprietory product per year.
- focusing on specific therapeutic areas such as Oncology and Infectious Disease.
We aim to generate profitability above industry average.